Yahoo
OTC Markets OTCPK - Delayed Quote USD

Novartis AG (NVSEF)

150.12 0.00 (0.00%)
At close: October 27 at 4:00:00 PM EDT
NVSEF Q3 2026 earnings call
Replay the call for the latest insights.
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
56,693,000
56,674,000
51,722,000
46,660,000
43,461,000
Cost of Revenue
14,319,000
13,699,000
12,827,000
12,472,000
11,582,000
Gross Profit
42,374,000
42,975,000
38,895,000
34,188,000
31,879,000
Operating Expense
25,272,000
25,331,000
24,351,000
24,419,000
23,933,000
Operating Income
17,102,000
17,644,000
14,544,000
9,769,000
7,946,000
Net Non Operating Interest Income Expense
-1,269,000
-980,000
-686,000
-419,000
-574,000
Other Income Expense
-311,000
-312,000
-218,000
-227,000
-195,000
Pretax Income
15,522,000
16,352,000
13,640,000
9,123,000
7,177,000
Tax Provision
2,775,000
2,385,000
1,701,000
551,000
1,128,000
Net Income Common Stockholders
12,757,000
13,984,000
11,941,000
14,850,000
6,955,000
Diluted NI Available to Com Stockholders
12,757,000
13,984,000
11,941,000
14,850,000
6,955,000
Basic EPS
6.67
7.21
5.92
7.15
3.19
Diluted EPS
6.62
7.15
5.87
7.10
3.17
Basic Average Shares
1,912,949.98
1,939,000
2,018,000
2,076,794.14
2,181,000
Diluted Average Shares
1,927,500
1,955,000
2,035,000
2,092,000
2,197,000
Total Operating Income as Reported
17,102,000
17,644,000
14,544,000
9,769,000
7,946,000
Total Expenses
39,591,000
39,030,000
37,178,000
36,891,000
35,515,000
Net Income from Continuing & Discontinued Operation
12,757,000
13,984,000
11,941,000
14,850,000
6,955,000
Normalized Income
13,003,366.45
14,240,243.88
12,098,552.79
8,769,160
6,204,112
Interest Income
--
373,000
568,000
627,000
377,000
Interest Expense
1,390,000
1,144,000
1,006,000
855,000
800,000
Net Interest Income
-1,269,000
-980,000
-686,000
-419,000
-574,000
EBIT
16,912,000
17,496,000
14,646,000
9,978,000
7,977,000
EBITDA
22,455,000
22,821,000
20,715,000
18,255,000
14,682,000
Reconciled Cost of Revenue
14,319,000
13,699,000
12,827,000
12,472,000
11,582,000
Reconciled Depreciation
5,543,000
5,325,000
6,069,000
8,277,000
6,705,000
Net Income from Continuing Operation Net Minority Interest
12,757,000
13,984,000
11,941,000
8,568,000
6,049,000
Total Unusual Items Excluding Goodwill
-300,000
-300,000
-180,000
-214,000
-184,000
Total Unusual Items
-300,000
-300,000
-180,000
-214,000
-184,000
Normalized EBITDA
22,755,000
23,121,000
20,895,000
18,469,000
14,866,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-53,633.55
-43,756.12
-22,447.21
-12,840
-28,888
12/31/2022 - 4/26/2010

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: